Disposable Incontinence Products Market Size and Share

Disposable Incontinence Products Market (2025 - 2030)
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Disposable Incontinence Products Market Analysis by Mordor Intelligence

The disposable incontinence products market generated USD 14.78 billion in 2025 and is projected to reach USD 20.68 billion in 2030, reflecting a 6.95% CAGR. At its current growth rate, the disposable incontinence products market is benefitting from longer life expectancy, wider chronic kidney disease (CKD) screening, and upgrades to reimbursement codes that expand coverage for hydrophilic catheters and other advanced devices. Protective garments remain the mainstay purchase in long-term care facilities, yet smart catheter designs and biodegradable nonwovens are widening clinician choice. Intensifying plastic-waste regulations in Europe are accelerating the shift toward recyclable packaging, while direct-to-consumer (D2C) platforms improve product access and brand loyalty in home-care settings. The disposable incontinence products market is also finding steady demand from hospital systems that integrate incontinence management into CKD and benign prostatic hyperplasia (BPH) care pathways.

Key Report Takeaways

  • By product type, protective garments led with 53.55% revenue share in 2024, whereas urinary catheters are set to expand at a 9.25% CAGR through 2030.
  • By application, chronic kidney failure accounted for 30.53% of the disposable incontinence products market size in 2024, while BPH management is advancing at an 8.15% CAGR to 2030.
  • By end-user, hospitals and clinics held 55.62% of the disposable incontinence products market share in 2024; home-care settings record the highest projected CAGR at 9.52% over the same period.
  • By geography, North America held 47.72% of 2024 revenue, while Asia-Pacific is advancing at a 10.22% CAGR to 2030.

Segment Analysis

By Product Type: Catheters Drive Innovation Despite Garment Dominance

Protective garments generated 53.55% of the disposable incontinence products market share in 2024, reflecting widespread adoption in hospitals, nursing homes, and at-home care routines. Demand is insulated from short-term economic swings because garments offer a familiar, low-training solution across mild-to-severe incontinence profiles. Innovations such as four-layer breathable panels and odor-lock gels extend wear time, thereby lowering daily change frequency for budget-tight facilities. Urinary catheters, while holding a smaller base, are advancing at a 9.25% CAGR as hydrophilic coatings reduce urethral trauma and new HCPCS reimbursement codes increase affordability. External catheter designs optimized for female anatomy are also winning regulatory clearance, opening untapped outpatient segments.

The disposable incontinence products market size for catheter solutions is forecast to rise steadily, supported by smart catheters that transmit real-time flow data to clinician dashboards. Disposable under-pads attract institutional buyers aiming to protect mattresses and wheelchairs against incidental leaks, while pull-up pants resonate with ambulatory adults seeking garment-like aesthetics. Leg urine bags gain share in home infusion programs where mobility is critical. Material upgrades in biodegradable polymers lower disposal costs, appealing to countries with landfill-tax regimes. The product-type landscape remains dynamic as cross-category hybrids—such as integrated diaper-catheter kits—enter clinical trials, promising further differentiation.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Application: BPH Growth Outpaces CKD Dominance

Chronic kidney failure retained 30.53% of the disposable incontinence products market size in 2024 because dialysis patients often require extended overnight protection. Hospitals bundle premium diapers into kidney-care reimbursement packages to prevent pressure ulcers and infections, ensuring stable-volume contracts through group-purchasing organizations. Yet BPH treatment is posting the fastest 8.15% CAGR. Earlier diagnostics and minimally invasive therapies allow men to resume daily routines more quickly, driving demand for discreet, high-absorbency pull-ups that can be worn under regular clothing. Clinical studies that correlate metabolic syndrome with BPH progression underscore the need for integrated urology-endocrinology care, expanding the disposable incontinence products market.

Bladder-cancer patients undergoing transurethral resections create episodic spikes in catheter use during recovery phases. Kidney-stone treatment protocols employ temporary leg bags to manage post-operative drainage, providing another periodic demand stream. Neurological disorders, from multiple sclerosis to spinal-cord injuries, require customized solutions that balance skin health and mobility, pushing R&D toward adaptive fasteners and pressure sensors. Future pipeline devices aim to pair pelvic-floor stimulation wearables with absorbent inserts, hinting at crossover categories that blur traditional application lines within the disposable incontinence products industry.

By End-User: Home-Care Acceleration Reshapes Distribution

Hospitals and clinics accounted for 55.62% of revenue in 2024 because institutional protocols mandate 24-hour protection for bed-bound patients and surgical wards. Centralized procurement grants volume leverage that squeezes supplier margins but assures forecast clarity. Long-term care facilities uphold consistent reorder cycles tied to resident census and acuity levels. Home-care, however, is expanding at a 9.52% CAGR as Medicare’s Advanced Primary Care Management program reimburses remote monitoring of chronic conditions. Subscription boxes ship multi-week diaper supplies directly to doorsteps, reducing caregiver trips to pharmacies and tapping new revenue pools for the disposable incontinence products market.

Smart diaper sensors, validated in clinical trials for dermatitis prevention, resonate with tech-savvy caregivers who appreciate smartphone alerts that guide change intervals. Home-infusion patients use leg bags that attach seamlessly to mobility aids, favoring brands that provide free telehealth setup advice. Growth in this channel encourages manufacturers to partner with logistics firms to optimize last-mile cold-chain segments for hydrogel-based catheters sensitive to temperature swings. As payers broaden lists of covered home-medical items, the disposable incontinence products market will continue shifting toward decentralized care ecosystems.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

North America led the disposable incontinence products market with a 42.72% revenue share in 2024, anchored by Medicare coding stability and mature long-term-care networks. Updated HCPCS codes effective January 2025 classify hydrophilic catheters in higher-reimbursement shells, prompting hospitals to upsell advanced variants. U.S. policy also widened coverage to lymphedema compression treatment items, signaling an overall device-friendly stance. Canada’s public health-insurance redesign expands home-support allowances, giving home-care suppliers greater wallet share. Mexico’s Seguro Popular replacement, INSABI, is channelling new funds to state clinics, creating a multi-tiered tender landscape. Sustainability mandates such as California’s SB 54, which enforces a 25% single-use plastic reduction by 2032, push brands to launch recyclable diaper wrappers that feed circular-economy pilots.

Asia-Pacific registered a 10.22% CAGR, the fastest globally, powered by population aging and higher CKD screening in China, Japan, and South Korea. China’s device makers are leveraging cost advantages to court Latin American buyers, exporting both pull-ups and catheter kits under CE-mark equivalency. Indonesia’s domestic factories benefit from government grants tied to local-content rules, supplying lower-priced diapers to public hospitals while premium imports capture the private-hospital tier. India’s e-pharmacies have started stocking discrete male guards and female pads, accelerating D2C penetration and adding volume to the disposable incontinence products market. Australia’s National Disability Insurance Scheme further boosts uptake of reusable pelvic-floor trainers that complement single-use absorbents.

Europe remains a mature yet evolving arena where the EU Packaging and Packaging Waste Regulation mandates fully recyclable packaging by 2030 and a 5% plastic-waste reduction by the same year. Manufacturers must balance sustainability upgrades with strict Medical Device Regulation (MDR) documentation that now covers reprocessed single-use devices. Germany leads volume consumption, yet France’s eco-tax credits tilt purchasing toward compostable liners. The United Kingdom’s NHS Supply Chain is piloting outcome-based contracts that tie reimbursements to dermatitis reduction metrics, potentially reshaping supplier scorecards. Nordic countries, already leaders in recyclable diaper adoption, offer case studies that other EU states may emulate, further influencing the disposable incontinence products market trajectory.

Growth Rate
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The disposable incontinence products market shows moderate consolidation: the top five manufacturers control a significant but not overwhelming portion of global revenue, leaving space for regional challengers. Kimberly-Clark’s adult-care division increased manufacturing capacity by more than 25% and targeted USD 3 billion in productivity savings, while investing in breathable nonwovens that align with its ESG roadmap. The 70% stake acquisition in Thinx enables entry into reusable underwear that counters single-use-plastic scrutiny and expands hybrid product offerings. Procter & Gamble supports its Always Discreet line with R&D spend that focuses on odor-locking channels and slimmer cores, leveraging USD 84 billion in 2024 net sales to cross-fund adult-care launches from baby-care learnings.

Essity (TENA), has translated Scandinavian sustainability standards into global roll-outs of plant-based topsheets and paper-based packaging. The company collaborates with recycling partners to close material loops, meeting EU waste benchmarks ahead of schedule. First Quality Enterprises expanded downstream by purchasing Henkel’s Retailer Brands and investing USD 400 million in Georgia and Pennsylvania diaper lines, a move that tightens quality control and reduces third-party dependency. Mid-tier entrants focus on AI-enabled sensors: start-ups license Bluetooth-connected moisture chips to traditional manufacturers that lack in-house electronics know-how, fostering mutually beneficial partnerships within the disposable incontinence products industry.

Regulatory compliance is becoming a strategic differentiator. MDR rules require notification of any supply interruption, forcing multinationals to secure dual-sourcing agreements for SAP resins. In the United States, the FDA Fast Track review for antimicrobial catheters shortens time-to-market for companies that can substantiate reduced infection rates. Venture funding gravitates toward firms with circular-economy narratives, especially in Europe where landfill levies tighten. Collectively, these dynamics spur a mix of defense-oriented acquisitions and offensive innovation pipelines, keeping competitive intensity at a steady yet manageable level across the disposable incontinence products market.

Disposable Incontinence Products Industry Leaders

  1. Essity

  2. Kimberly-Clark

  3. Procter & Gamble

  4. Unicharm

  5. Cardinal Health

  6. *Disclaimer: Major Players sorted in no particular order
Disposable Incontinence Products Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • June 2025: Kimberly-Clark sold a majority stake in its international tissue unit to Suzano for USD 3.4 billion while retaining 49% ownership, freeing capital to focus on core personal-care categories including incontinence products.
  • February 2025: The European Union enacted the Packaging and Packaging Waste Regulation that requires all packaging to be recyclable by 2030 and sets a 5% plastic-reduction target by 2030, compelling disposable incontinence product makers to redesign material choices.

Table of Contents for Disposable Incontinence Products Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence Of Renal & Urological Disorders
    • 4.2.2 Aging Population & Higher Life Expectancy
    • 4.2.3 Advances In Super-Absorbent & Breathable Nonwovens
    • 4.2.4 E-Commerce & D2C Brands Expanding Access
    • 4.2.5 2026 HCPCS Codes For Hydrophilic Catheters (Reimbursement Boost)
    • 4.2.6 Adoption Of AI-Enabled Smart Diapers In Long-Term Care
  • 4.3 Market Restraints
    • 4.3.1 Dermatitis & Infection Risks From Prolonged Product Use
    • 4.3.2 Patchy Reimbursement In Emerging Economies
    • 4.3.3 Sustainability Regulations On Single-Use Plastics & Landfill Waste
    • 4.3.4 Shift Toward Reusable Pelvic-Floor Wearables & Stimulation Devices
  • 4.4 Porter's Five Forces
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitutes
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product Type
    • 5.1.1 Protective Garments
    • 5.1.1.1 Disposable Adult Diapers
    • 5.1.1.2 Disposable Under-pads
    • 5.1.1.3 Disposable Pull-up Pants
    • 5.1.1.4 Other Garments
    • 5.1.2 Urine Bags
    • 5.1.2.1 Leg Urine Bags
    • 5.1.2.2 Bedside Urine Bags
    • 5.1.3 Urinary Catheters
    • 5.1.3.1 Indwelling (Foley) Catheters
    • 5.1.3.2 Intermittent Catheters
    • 5.1.3.3 External Catheters
  • 5.2 By Application
    • 5.2.1 Chronic Kidney Failure
    • 5.2.2 Benign Prostatic Hyperplasia (BPH)
    • 5.2.3 Bladder Cancer
    • 5.2.4 Kidney Stone
    • 5.2.5 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospitals & Clinics
    • 5.3.2 Long-Term Care Facilities
    • 5.3.3 Homecare Settings
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 Becton, Dickinson & Co. (C.R. Bard)
    • 6.3.2 Cardinal Health
    • 6.3.3 Coloplast
    • 6.3.4 Kimberly-Clark
    • 6.3.5 Abena
    • 6.3.6 Hollister
    • 6.3.7 ConvaTec
    • 6.3.8 First Quality Enterprises
    • 6.3.9 HARTMANN Group
    • 6.3.10 Medline Industries
    • 6.3.11 Essity
    • 6.3.12 Procter & Gamble
    • 6.3.13 Unicharm Corp.
    • 6.3.14 Teleflex Inc.
    • 6.3.15 B. Braun Melsungen AG
    • 6.3.16 Boston Scientific
    • 6.3.17 Ontex Group
    • 6.3.18 TZMO SA
    • 6.3.19 Principle Business Enterprises

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment

Research Methodology Framework and Report Scope

Market Definitions and Key Coverage

Our study defines the disposable incontinence products (DIP) market as single-use absorbent garments, urine bags, and urinary catheters that reach users through retail, institutional, and e-commerce channels to manage urine or fecal leakage in adults and adolescents. According to Mordor Intelligence, values are captured at first commercial sale in US dollars.

Reusable cloth briefs, prescription medications, and surgical implants are excluded from this assessment.

Segmentation Overview

  • By Product Type
    • Protective Garments
      • Disposable Adult Diapers
      • Disposable Under-pads
      • Disposable Pull-up Pants
      • Other Garments
    • Urine Bags
      • Leg Urine Bags
      • Bedside Urine Bags
    • Urinary Catheters
      • Indwelling (Foley) Catheters
      • Intermittent Catheters
      • External Catheters
  • By Application
    • Chronic Kidney Failure
    • Benign Prostatic Hyperplasia (BPH)
    • Bladder Cancer
    • Kidney Stone
    • Other Applications
  • By End-User
    • Hospitals & Clinics
    • Long-Term Care Facilities
    • Homecare Settings
  • Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Middle East and Africa
      • GCC
      • South Africa
      • Rest of Middle East and Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Detailed Research Methodology and Data Validation

Primary Research

Targeted interviews and short surveys with procurement managers at long-term care homes, retail buyers, urologists, and material suppliers across North America, Europe, and Asia-Pacific helped us verify channel splits, catheter penetration, and price dispersion that secondary data alone could not reveal.

Desk Research

We gathered baseline supply-demand signals from the UN Population Prospects, WHO Global Health Observatory, United Nations Comtrade shipment codes for HS 961900, and briefs issued by EDANA plus the International Continence Society. Company 10-Ks, quarterly filings, patent families mined via Questel, and super-absorbent polymer price indices from Polymer Update added context.

Because market activity is fragmented across care settings, these sources provided mainly direction. Our team therefore relied on Dow Jones Factiva, national hospital discharge datasets, and consumer health surveys to cross-check volumes and average selling prices. The references listed are illustrative; many additional publications informed data validation.

Market-Sizing & Forecasting

A top-down incidence-to-treated-pool construct converts prevalence of moderate-to-severe incontinence, nursing-home resident counts, and catheter utilization rates into unit demand, which is then tested with selective bottom-up supplier roll-ups. Key variables such as geriatric population, incontinence prevalence ratios, super-absorbent polymer price trends, median diaper ASP, hospital bed capacity, and e-commerce share feed a multivariate regression that projects value through 2030. Where primary feedback flags gaps, elasticities are tuned before final sign-off.

Data Validation & Update Cycle

Model outputs are compared with customs records, quarterly earnings, and peer forecasts. Any anomaly triggers analyst re-checks. Reports refresh each year, and interim updates follow material events so clients receive the latest view.

Why Mordor's Disposable Incontinence Products Baseline Commands Reliability

Published estimates differ because firms adopt varying scopes, price assumptions, and refresh cadences. Common gap drivers include counting reusable linens, omitting catheters, or relying on wholesale price books without retail mark-ups, each of which shifts totals versus our disciplined scope.

These contrasts show how Mordor's clearly defined scope, yearly refresh, and variable-level triangulation create a balanced, transparent baseline that decision-makers can trace and replicate with confidence.

Benchmark comparison

Market Size Anonymized source Primary gap driver
USD 14.78 Bn (2025) Mordor Intelligence
USD 15.50 Bn (2025) Global Consultancy A Combines reusable pads and wet wipes with disposables
USD 15.46 Bn (2025) Trade Journal B Applies wholesale list prices, excludes retail margins
USD 14.81 Bn (2025) Industry Publisher C Tracks only absorbent garments, omits catheters and urine bags

Key Questions Answered in the Report

What is the current size of the disposable incontinence products market?

The disposable incontinence products market generated USD 14.78 billion in 2025 and is forecast to reach USD 20.68 billion by 2030, reflecting a 6.95% CAGR.

Which product segment is growing the fastest?

Urinary catheters constitute the fastest-growing product segment, expanding at a 9.25% CAGR through 2030 on the back of hydrophilic coatings and favorable reimbursement updates.

Why is Asia-Pacific the fastest-growing regional market?

Aging demographics and expanding health-insurance coverage are driving a 10.22% CAGR in Asia-Pacific, with the older-adult population projected to double by 2050.

How are sustainability regulations affecting manufacturers?

The EU Packaging and Packaging Waste Regulation mandates fully recyclable packaging by 2030, pushing manufacturers to invest in biodegradable absorbents and paper-based wraps.

What role do smart technologies play in product innovation?

AI-enabled diaper sensors and data-linked catheters help caregivers time changes accurately and reduce dermatitis, making connectivity a key differentiator in premium tiers of the disposable incontinence products industry.

Page last updated on:

Disposable Incontinence Products Report Snapshots